Trial Profile
An Independent, Multicenter, Postmarketing Study Comparing the Effectiveness of Fingolimod (FNG) and Dimethyl fumarate (DMF) in a Large Cohort of Italian Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2018
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 06 Jul 2018 New trial record
- 06 Jun 2018 Results published in the Neurology Journal.